Steel Grove Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Steel Grove Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	33,428 +166	+0.5%	+$9.53K	0.18%	66
2026 Q1	$2.02M	Buy	33,262 +554	+2%	+$32.3K	0.21%	46
2025 Q4	$1.76M	Sell	32,708 -590	-2%	-$28.4K	0.18%	54
2025 Q3	$1.54M	Sell	33,298 -5,000	-13%	-$234K	0.18%	81
2025 Q2	$4.63M	Buy	38,298 +4,108	+12%	+$202K	0.55%	21
2025 Q1	$2.09M	Sell	34,190 -2,120	-6%	-$124K	0.32%	40
2024 Q4	$2.05M	Sell	36,310 -7,183	-17%	-$401K	0.28%	36
2024 Q3	$2.21M	Buy	43,493 +10,313	+31%	+$484K	0.31%	32
2024 Q2	$1.38M	Sell	33,180 -4,477	-12%	-$200K	0.19%	73
2024 Q1	$2.04M	Buy	37,657 +30,718	+443%	+$1.56M	0.27%	45
2023 Q4	$356K	Sell	6,939 -22,883	-77%	-$1.2M	0.05%	128
2023 Q3	$1.73M	Buy	29,822 +236	+0.8%	+$14.5K	0.23%	68
2023 Q2	$1.89M	Buy	29,586 +314	+1%	+$21.1K	0.24%	66
2023 Q1	$2.03M	Buy	29,272 +1,085	+4%	+$76.5K	0.27%	55
2022 Q4	$2.03M	Buy	28,187 +578	+2%	+$43.6K	0.29%	51
2022 Q3	$1.96M	Buy	27,609 +73	+0.3%	+$5.29K	0.35%	34
2022 Q2	$2.12M	Buy	27,536 +9	+0%	+$685	0.39%	29
2022 Q1	$2.01M	Buy	27,527 +18,333	+199%	+$1.23M	0.32%	37
2021 Q4	$573K	Sell	9,194 -16,158	-64%	-$948K	0.11%	81
2021 Q3	$1.5M	Buy	25,352 +1,088	+4%	+$71.7K	0.34%	54
2021 Q2	$1.62M	Buy	24,264 +3,735	+18%	+$244K	0.44%	51
2021 Q1	$1.3M	Buy	20,529 +292	+1%	+$18.2K	0.42%	58
2020 Q4	$1.25M	Buy	+20,237	New	+$1.24M	0.41%	52
2019 Q1	–	Sell	-4,178	Closed	-$217K	–	143
2018 Q4	$217K	Buy	4,178 +289	+7%	+$15.5K	0.03%	288
2018 Q3	$241K	Buy	3,889 +76	+2%	+$4.51K	0.03%	276
2018 Q2	$211K	Sell	3,813 -165	-4%	-$8.91K	0.03%	287
2018 Q1	$252K	Buy	3,978 +200	+5%	+$12.9K	0.04%	266
2017 Q4	$232K	Sell	3,778 -2,050	-35%	-$128K	0.03%	269
2017 Q3	$371K	Buy	5,828 +2,000	+52%	+$117K	0.07%	198
2017 Q2	$213K	Sell	3,828 -5,000	-57%	-$272K	0.04%	257
2017 Q1	$480K	Buy	8,828 +450	+5%	+$24.7K	0.08%	170
2016 Q4	$490K	Sell	8,378 -500	-6%	-$27.3K	0.1%	150
2016 Q3	$479K	Buy	8,878 +28	+0.3%	+$1.8K	0.11%	114
2016 Q2	$651K	Buy	8,850 +1,000	+13%	+$70.7K	0.16%	89
2016 Q1	$504K	Buy	7,850 +500	+7%	+$31.5K	0.13%	94
2015 Q4	$508K	Hold	7,350	–	–	0.13%	113
2015 Q3	$438K	Buy	+7,350	New	+$466K	0.11%	113
2015 Q2	–	Sell	-9,350	Closed	-$603K	–	195
2015 Q1	$603K	Buy	+9,350	New	+$585K	0.14%	86

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Steel Grove Capital Advisors's BMY Position: Q2 2026 in Review

Steel Grove Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.5% in Q2 2026, buying an estimated $9.53K and bringing the position to 33,428 shares worth $1.93M. The position accounts for 0.18% of the portfolio, ranked #66.

Steel Grove Capital Advisors first reported a position in BMY in Q1 2015 and has held it in 38 quarters since. The position peaked at $4.63M in Q2 2025. 930 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Steel Grove Capital Advisors held 33,428 shares of Bristol-Myers Squibb worth $1.93M as of Q2 2026.
Steel Grove Capital Advisors bought 166 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.53K.
Bristol-Myers Squibb made up 0.18% of Steel Grove Capital Advisors's portfolio in Q2 2026, its #66 holding.
Steel Grove Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 38 quarters since.
Steel Grove Capital Advisors's Bristol-Myers Squibb position peaked at $4.63M in Q2 2025.
930 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Steel Grove Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.